Ona G
ANIMA Group. Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Spain.
ArticlePsilocybin
Time to embrace the whole: considering the replacement of psilocybin with <i>Psilocybe</i> spp. in psychedelic research and therapy.
ArticlePsychedelics
Current perspectives on psychedelic treatments in Europe.
ArticleDMT
Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.
ArticleAyahuasca
Corrigendum: Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment.
ArticleIbogaine
A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets.
ArticleAyahuasca
Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment.
ArticleIbogaine
Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.
ArticlePsychedelics
Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic.
ArticleAyahuasca
Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial.
ArticlePsychedelics
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
ArticleIbogaine
Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences.
ArticleAyahuasca
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials.
ArticlePsychedelics
The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A.
ArticlePsilocybin
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.
ArticlePsilocybin
Psychedelic Medicines in Major Depression: Progress and Future Challenges.
ArticlePsilocybin
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.
ArticleAyahuasca